首页> 美国卫生研究院文献>BMC Cancer >Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases

【2h】

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases

机译：Trastuzumab Emtansine（T-DM1）和刻膜辐射在HER2 +乳腺癌脑转移中的管理中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Patient and Treatment Characteristics

机译：患者和治疗特征

著录项

期刊名称 BMC Cancer
作者
Matthew N. Mills; Chelsea Walker; Chetna Thawani; Afrin Naz; Nicholas B. Figura; Sergiy Kushchayev; Arnold Etame; Hsiang-Hsuan Michael Yu; Timothy J. Robinson; James Liu; Michael A. Vogelbaum; Peter A. Forsyth; Brian J. Czerniecki; Hatem H. Soliman; Hyo S. Han; Kamran A. Ahmed;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词
Trastuzumab emtansine; Kadcyla; Breast cancer; Brain metastases; Stereotactic radiotherapy;

机译：Trastuzumab Omtansine;kadcyla;乳腺癌;脑转移;立体定向放射疗法;

相似文献

外文文献
中文文献
专利

1. Can trastuzumab emtansine be replaced by additional chemotherapy plus targeted therapy for HER2-overexpressing breast cancer patients with residual disease after neoadjuvant chemotherapy? [J] . Juan Wu, Rong Kong, Shen Tian, 中国癌症研究（英文版） . 2019 ,第006期
2. Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2 breast cancer brain metastases [J] . Matthew N. Mills, Chelsea Walker, Chetna Thawani, BMC Cancer . 2021 ,第1期

机译：Trastuzumab Emtansine（T-DM1）和立体定向辐射在HER2乳腺癌脑转移中的管理中
3. The evolving role of trastuzumab emtansine (T-DM1) in HER2-positive breast cancer with brain metastases [J] . Dong Rongrong, Ji Jiali, Liu Hong, Critical reviews in oncology/hematology . 2019 ,第期

机译：Trastuzumab Emtansine（T-DM1）在脑转移中曲妥珠单抗（T-DM1）在Her2阳性乳腺癌中的不断发展作用
4. Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases [J] . Jacot William, Pons Elvire, Frenel Jean-Sebastien, Breast cancer research and treatment. . 2016 ,第2期

机译：曲妥珠单抗坦坦碱（T-DM1）在HER2阳性脑转移性乳腺癌患者中的疗效和安全性
5. The role of Mass Spectrometry in Antibody Drug Conjugate Drug Development: Trastuzumab emtansine (T-DM1) [C] . Ola M. Saad, Keyang Xu, Luna Liu, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：质谱法在抗体药物缀合物药物发育中的作用：曲妥珠单抗（T-DM1）
6. Development of PET Imaging Probes for Predicting Response of Breast Cancer to Trastuzumab Emtansine (T-DM1) [D] . Al-saden, Noor. 2019

机译：宠物成像探针的发展，以预测乳腺癌对曲妥珠单抗的响应（T-DM1）
7. Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective exploratory analysis in EMILIA [O] . I. E. Krop, N. U. Lin, K. Blackwell, -1

机译：曲妥珠单抗Emtansine（T-DM1）与拉帕替尼联合卡培他滨治疗HER2阳性转移性乳腺癌和中枢神经系统转移的患者：EMILIA的回顾性探索性分析
8. Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases [O] . Matthew N. Mills, Chelsea Walker, Chetna Thawani, 2021

机译：Trastuzumab Emtansine（T-DM1）和刻膜辐射在HER2 +乳腺癌脑转移中的管理中

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases

摘要

著录项

相似文献

相关主题

期刊订阅